This course provides pharmacists with insights into the pathophysiology and epidemiology of Respiratory Syncytial Virus (RSV) infection and the current epidemiology of influenza, COVID-19, and long-COVID. Course content will explore preventative strategies to mitigate complications for each of these respiratory viruses and review the latest updates in vaccine recommendations. Through interactive case discussions, learners will apply the pharmacist patient care process to real-world scenarios and be equipped to deliver optimal patient care and guidance for common respiratory viruses.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Explain the pathophysiology and epidemiology of respiratory syncytial virus (RSV) infection.
2. Describe effective preventative measures to reduce complications of RSV infection.
3. Discuss the current epidemiology of COVID-19, including Long COVID.
4. Review the latest epidemiology and vaccine recommendations for influenza.
5. Apply the pharmacist patient care process to a patient case focused on respiratory viruses.

Elizabeth Skoy, PharmD
Professor
North Dakota State University

Elizabeth Skoy has no relevant financial relationships with ineligible companies to disclose. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: January 15, 2024
Planned Expiration Date: January 15, 2027

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.